Abstract
Anti-CD47 and Anti-PDL1 Immunotherapy Synergize for Anti-tumor Activity in Preclinical Models of Head and Neck Cancer
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology, Biology, Physics
Paper Title
Journal
Date